| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_425ba7ed05a2195fe1fa4a281598e615
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a9a8cccb127119b386415916a97d354e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9cc16135dbe731138c0a05c9bc242d38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a48132fcc2f50a7107021f911f887cb |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-24 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-04 |
| filingDate |
1999-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d3c10dca94df4077af18aa36b840fd9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87f4519c2e69a51796f5a1f6603c6821
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_666f609930d06830dbb946518f6f1b5b |
| publicationDate |
2000-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0018423-A1 |
| titleOfInvention |
Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of lh-rh analogues |
| abstract |
The invention relates to the use of α-cyclodextrin or a derivative thereof for the preparation of pharmaceutical compositions for the oral administration of LH-RH peptide analogues. The invention also relates to oral pharmaceutical compositions containing LH-RH peptide analogues in combination with α-cyclodextrin or a derivative thereof. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011213733-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7057014-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03055900-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003533466-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100880828-B1 |
| priorityDate |
1998-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |